Form D Explorer

Form C-AR — Berkshire Biomedical Corp

0001665160-25-000999 · filed 2025-05-06

Offering

Target: —
Maximum: —
Security type: —
Price per security: —
Deadline: —
Oversubscription: —

Issuer

Name: Berkshire Biomedical Corp
CIK: 2048576
Entity: Corporation
Jurisdiction: DE
Address: 5950 BERKSHIRE LN., SUITE 375
DALLAS, TX 75225
Phone: —

Most recent fiscal year financials

Total assets

$173,383

Cash

—

Short-term debt

—

Long-term debt

$9,535,643

Revenues

$221,860

COGS

—

Taxes paid

—

Net income

$-4,258,282

Likely investment adviser (not guaranteed)

BERKSHIRE CAPITAL HOLDINGS INC
medium CRD 801-53149
BERKSHIRE PARTNERS LLC
medium CRD 801-73336

View original on SEC EDGAR.